Skip to content

Sanara MedTech Inc. SMTI Additional Paid-In Capital

Additional Paid-In Capital at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$19.77B-1.0%
Stryker logo
StrykerSYK
$2.65B+8.5%
IAR
Integra LifeSciencesIART
$1.34B+1.3%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$820.25M+4.3%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$239.47M+10.3%
Anika Therapeutics logo
Anika TherapeuticsANIK
$83.35M-4.8%

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s additional paid-in capital?
Sanara MedTech Inc. (SMTI) reported additional paid-in capital of $81.52M in Q1 2026.
How has Sanara MedTech Inc.'s additional paid-in capital changed year-over-year?
Sanara MedTech Inc.'s additional paid-in capital increased by 4.6% year-over-year, from $77.97M to $81.52M.
What is the long-term trend for Sanara MedTech Inc.'s additional paid-in capital?
Over 5 years (2020 to 2025), Sanara MedTech Inc.'s additional paid-in capital has grown at a 43.9% compound annual growth rate (CAGR), from $13.18M to $81.23M.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.